A comparative study of a new selective beta 2-adrenoceptor agonist, procaterol and salbutamol in asthma
- PMID: 2862893
- PMCID: PMC1463871
- DOI: 10.1111/j.1365-2125.1985.tb02715.x
A comparative study of a new selective beta 2-adrenoceptor agonist, procaterol and salbutamol in asthma
Abstract
The effects of single oral doses of a new selective beta 2-adrenoceptor agonist procaterol (0.05 mg and 0.1 mg) and salbutamol (4 mg) on ventilatory function, were compared in 24 asthmatic patients. A bronchodilator effect of similar duration and magnitude followed all three treatments with no evidence of a dose-related response in the case of procaterol. There was no significant difference in blood pressure or heart rate responses or pattern of unwanted effects. We conclude that procaterol and salbutamol are clinically similar with oral dosing and that the maximum effective dose of procaterol is not greater than 0.05 mg.
Similar articles
-
Inhaled procaterol versus salbutamol in bronchial asthma.Eur J Clin Pharmacol. 1991;40(4):417-8. doi: 10.1007/BF00265855. Eur J Clin Pharmacol. 1991. PMID: 1828765 Clinical Trial.
-
Duration of oral procaterol protection from methacholine-induced bronchial obstruction.Int J Clin Pharmacol Res. 1986;6(5):403-7. Int J Clin Pharmacol Res. 1986. PMID: 2877955 Clinical Trial.
-
Comparison of cardiorespiratory effects of procaterol and salbutamol in asthmatic patients.J Med Assoc Thai. 1982 Feb;65(2):86-94. J Med Assoc Thai. 1982. PMID: 6122706 Clinical Trial. No abstract available.
-
[Pharmacological action of SN-408, a novel long-acting selective beta 2-adrenoceptor agonist].Nihon Yakurigaku Zasshi. 1991 Jul;98(1):7-21. doi: 10.1254/fpj.98.1_7. Nihon Yakurigaku Zasshi. 1991. PMID: 1679741 Japanese.
-
The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients.Int J Clin Pharmacol Biopharm. 1975 Jul;12(1-2):158-69. Int J Clin Pharmacol Biopharm. 1975. PMID: 240780 Clinical Trial.
Cited by
-
Salbutamol in the 1980s. A reappraisal of its clinical efficacy.Drugs. 1989 Jul;38(1):77-122. doi: 10.2165/00003495-198938010-00004. Drugs. 1989. PMID: 2670512 Review.
-
Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.Handb Exp Pharmacol. 2024;285:369-451. doi: 10.1007/164_2023_679. Handb Exp Pharmacol. 2024. PMID: 37709918 Review.
-
Inhaled procaterol versus salbutamol in bronchial asthma.Eur J Clin Pharmacol. 1991;40(4):417-8. doi: 10.1007/BF00265855. Eur J Clin Pharmacol. 1991. PMID: 1828765 Clinical Trial.
-
Effects of Oral Doxofylline and Procaterol on Chronic Obstructive Pulmonary Disease: A Randomized Crossover Study.Med Sci (Basel). 2025 Apr 29;13(2):49. doi: 10.3390/medsci13020049. Med Sci (Basel). 2025. PMID: 40407544 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical